Related by context. All words. (Click for frequent words.) 71 KRYSTEXXA TM pegloticase 69 Acetavance TM 68 mesylate tablets approved 68 commercialize CorMedix drug 66 Crofelemer budesonide foam 66 candidate REP# 66 Initiates Enrollment 66 Resubmission 66 granted Ortec 66 Receives Approvable Letter 66 XL# anticancer compounds 66 Empatic ™ 65 Announces Tentative Approval 65 Submits Supplemental 65 Files Investigational 65 Oral Calcitonin 65 Submits NDA 65 FACTIVE R gemifloxacin 65 Oracea TM 65 Medicure Announces 65 Submits Biologics License Application 65 markets HP Acthar 65 novel orally inhaled 65 please visit www.medicinova.com 65 pharmacogenomic translational research 65 Telik Announces 65 Completes Patient Enrollment 64 FDA Accepts 64 DIFICID ™ 64 BioGlue ® 64 Pegloticase 64 sNDAs 64 VIVITROL ® 64 AcryMed technologies 64 Initiates Phase II 64 subsidiaries visit http:/www.apricusbio.com 64 CORLUX CORT # 64 Panzem R 64 Kosan dependence 64 Biologic License Application BLA 64 SILENOR 64 ELADUR ™ 64 candidate deforolimus 64 proprietary intravenous formulation 63 Cardium Therapeutics TM 63 pralatrexate injection folate analogue 63 corticotropin injection 63 FOLOTYN ® 63 Pruvel TM 63 AVI BioPharma Announces 63 OMAPRO ™ 63 Receives Complete Response 63 TRANSDUR ® 63 zolpidem tartrate sublingual tablet 63 Initiates Phase III 63 Announce Shareholder Approval 63 SPL# Gel vaginal microbicide 63 Soliris TM eculizumab 63 XP# XP# 63 Generx TM 63 visit www.targanta.com 63 Zemiva TM 63 visit www.sciclone.com 63 SinuNase ™ 63 product platforms AZX# 63 highly purified pasteurized 63 BioSante Pharmaceuticals Announces 63 Complete Liquidation 63 Pruvel ™ prulifloxacin 63 TRIOLEX HE# APOPTONE HE# 63 Auxilium anticipates 63 CRMD# 63 Staphylococcus aureus Immune Globulin 63 IV APAP 63 Files IND 63 Somatuline R Autogel R 63 dextromethorphan quinidine 63 TRANSDUR ™ 63 Zenvia ™ 63 NDA Submission 63 JAK2 Inhibitor 63 LibiGel ® 63 ® decitabine 62 BioSante licensees 62 novel emulsion formulation 62 Salix Pharmaceuticals Announces 62 Receives Tentative Approval 62 candidates Azedra TM 62 website www.nyandcompany.com 62 website www.celsion.com 62 balsalazide tablet 62 BiovaxID TM 62 sumatriptan succinate injection 62 Surfaxin LS 62 Aeolus Pharmaceuticals Announces 62 successfully commercialize Iluvien 62 TAFA# 62 KRYSTEXXA ™ 62 NMT Medical Announces 62 nasal calcitonin product 62 PDX pralatrexate 62 Vitamin D analogue 62 5 lipoxygenase inhibitor 62 successfully commercialize Silenor 62 Zemiva TM Trofex TM 62 dihydrochloride Tablets 62 Entereg TM 62 please visit www.middlebrookpharma.com 62 Phase III Clinical Trial 62 semi synthetic lipoglycopeptide 62 www.pranabio.com 62 please visit www.cpexpharm.com 62 GATTEX TM 62 Teva Provides Update 62 markets COLAZAL 62 Hematide ™ peginesatide 62 PROVENGE ® 62 Hematide ™ 62 dihydrochloride Phase 3 62 ThermoDox ® clinical 62 Empatic TM 62 Submits Investigational 62 Vitrasert R 62 Patient Enrollment 62 treat hyperproliferative disorders 62 Orapred ODT 62 Nabi HB Intravenous 62 VYVANSE TM lisdexamfetamine 62 ZEGERID Capsules 62 proprietary Capillary Aerosolization Technology 62 Medoro Resources Announces 62 Marketing Approval PMA 62 topical non steroidal 62 Issues Complete Response 61 REMOXY R 61 topically applied SEPA 61 Mylan Receives Approval 61 REMOXY POSIDUR ELADUR 61 Personalized Immunotherapy 61 CIP TRAMADOL ER 61 tizanidine hydrochloride short 61 MelaFind R 61 topical antifungal product 61 Anidulafungin 61 LEVADEX TM 61 Palatin intends 61 Biological License Application 61 ELADUR TM 61 Granted Orphan Drug 61 Submits Response 61 Peyronie disease Frozen Shoulder 61 NUEDEXTA ™ 61 Novel Antibiotic 61 Silenor ® doxepin 61 INTEGRILIN R eptifibatide Injection 61 Amigal TM 61 signal detection CTSD 61 cladribine Cladribine Tablets 61 Abstract Accepted 61 sapacitabine CYC# 61 ENABLE Phase 2 61 Initiate Phase II 61 Receives CE Marking 61 Lorus Therapeutics Announces 61 please visit www.advaxis.com 61 Xcytrin R 61 novel MetAP 2 61 Synerx 61 XL# XL# 61 MOVIPREP R 61 Liprotamase 61 Receives Tentative FDA 61 SYCREST 61 AAG geldanamycin analog 61 REMOXY NDA 61 R MSCRAMM 61 coronary stent merged 61 faropenem medoxomil 61 Quinton Hennigh Ph.D. P.Geo 61 Aloprim TM allopurinol sodium 61 Nuvelo Announces 61 Solazed TM 61 Biologics License Applications 61 SUTENT ® 61 TRIOLEX ™ 61 developing ostarine selective 61 thrombin component 61 candidate SILENOR TM 61 Anturol TM 61 Dementia Related Psychosis 61 manufactures minimally invasive 61 HP Acthar Gel repository 61 evaluating satraplatin 61 SILENOR ™ 61 Urocidin TM 61 SinuNase TM 61 palonosetron hydrochloride Injection Dacogen 61 Sangamo BioSciences Announces 60 Taro Receives 60 molecular imaging radiopharmaceutical 60 OvaRex R 60 ™ pralatrexate injection 60 overactive bladder AA# 60 ENGINEERING.com Incorporated Announces 60 Contrave NDA 60 Stavzor TM 60 ATPace 60 Rosetta dependence 60 Dyax logo 60 please visit http:/www.atherogenics.com 60 Audited Financials 60 transthyretin mediated amyloidosis ATTR 60 Theratechnologies Announces 60 VIVUS Announces 60 ZEGERID Powder 60 BRILINTA 60 HYVISC ® treatment 60 Presents Positive 60 #-# www.pardeehospital.org 60 vii Cubist ability 60 Successfully Completes Phase 60 Initiates Phase 2b 60 BLA filing 60 Sumatriptan Succinate 60 please visit www.sucampo.com 60 novel trazodone formulation 60 SWX BSLN 60 GATTEX ™ 60 androgen receptor modulator 60 Zemiva ™ 60 Coalcorp Provides Updated 60 Solzira TM 60 IMPDH inhibitor 60 Receives Fast Track 60 miconazole MBT 60 severe hypercholesterolemia 60 Biologic License Application 60 TB4 mechanisms 60 Carbidopa Levodopa 60 Hsp# Inhibitor 60 estradiol transdermal spray 60 liver resection surgeries 60 Metabasis dependence 60 Romidepsin 60 Spectrum Pharmaceuticals Announces 60 please visit http:/www.vandapharma.com 60 Receives Orphan Drug 60 Cutanea Life Sciences 60 Gentamicin Surgical Implant 60 hypoxia activated prodrug 60 include Phenoptin TM 60 Prestara TM 60 autologous cellular immunotherapy 60 symbol AVXL 60 oral picoplatin 60 ENZON 60 Hedgehog Pathway Inhibitor 60 Visit CTT 60 POSIDUR TM ELADUR TM 60 IMiDs R 60 www.transcept.com 60 Dexilant 60 RealPennies.com RealPennies.com 60 Inc. ProMetic www.prometic.com 60 zileuton IV 60 methylnaltrexone bromide 60 Aradigm Logo 60 visit www.novabaypharma.com 60 D. Medicals 60 Veronate R 60 Initiates Clinical Trial 60 Surgical Adhesive 60 indiplon capsules 60 Azedra TM Onalta TM 60 R sipuleucel T 60 LibiGel NDA 60 Initiates Clinical 60 Receives Orphan Drug Designation 60 vinorelbine emulsion 60 BEMA Granisetron 60 Aganocide 60 Diamyd Medical Diamyd 60 Velaglucerase Alfa 60 include Ischemic Paraplegia 60 PDUFA Date 60 DARA logo 60 delivers fluocinolone acetonide FA 60 developing ACAPODENE 60 STRIKE PRICE COMPARES TO 60 Telik logo TELINTRA 60 BRE Properties Announces 60 Augment ™ 60 solid tumors ZYBRESTAT 60 Intermezzo ® NDA 60 recurrent metastatic ovarian cancer 60 Anturol ® 60 number NCT# ClinicalTrials.gov 60 orBec ® oral beclomethasone 60 Omigard TM 60 Crowflight Announces 60 Severe hypersensitivity reactions 60 Methylphenidate Transdermal System 60 Alnylam dependence 60 XL# XL# XL# XL# 60 Company Skouries Olympias 59 ALTROPANE R 59 website http:/www.celsion.com 59 Inc. www.micromet inc.com 59 OTC ZEGERID 59 Phase 2a Trial 59 Nanophase Technologies Announces 59 Company website www.anormed.com 59 Testosterone MDTS ® 59 Intermezzo ® zolpidem tartrate 59 Goggin holed 59 Amgen Bayer Schering 59 AcryMed Incorporated 59 Investigational Oral 59 platform HDL Mimetic 59 fluvoxamine maleate 59 MKC# MKC# PP 59 Polyphenon ® E 59 commercialize ZYFLO CR 59 Cellegesic 59 Feraheme ® 59 http:/www.viropharma.com 59 Osisko Releases 59 Initiate Clinical Trial 59 malignant mesothelioma Alfacell 59 including eniluracil ADH 59 Dayle Rusk P. Geo 59 Wolf Haldenstein Investigates 59 Allovectin 7 r 59 * Potentially libelous 59 proprietary intranasal insulin 59 LEVADEX ™ 59 TSX VENTURE GAP 59 SABESP Announces 59 http:/www.generex.com 59 NexMed Receives 59 refractory chronic lymphocytic 59 Nycomed GmbH 59 TranSwitch indebtedness 59 PLK1 SNALP 59 Includes gourmet coffees 59 Budesonide foam crofelemer 59 Gout Drug 59 CoTherix logo 59 CCR5 inhibitors entry 59 Dyloject TM 59 Earns Milestone Payment 59 EVIZON TM squalamine lactate 59 SEDAR Filings 59 banned Darvon Darvocet 59 novel therapeutic antibodies 59 include ClindaReach TM 59 Employment Inducement Awards 59 polysaccharide polymer 59 Levoleucovorin 59 Files Voluntary 59 Pre IND 59 SPARLON 59 InvaGen 59 dimebon latrepirdine 59 Receives Milestone Payment 59 HP Acthar R 59 Closes Non Brokered 59 diagnostic molecular imaging 59 Through Glycoscience R 59 5 HT2A inverse 59 include PLX IBD 59 Morphine Sulfate 59 Meets Primary Endpoint 59 trastuzumab DM1 T DM1 59 includes TOLAMBA TM 59 Rexahn licensees 59 TRANSDUR Sufentanil 59 FDA Complete Response 59 oxandrolone USP 59 PrevOnco 59 Iluvien ® 59 Therapeutic Competitors companiesandmarkets.com adEgemonye 59 Submits IND 59 Generic Version 59 diabetes irritable bowel 59 Phase IIb Clinical Trial 59 BEMA ® 59 ARRY # 59 Exelixis compounds 59 Teikoku Pharma USA 59 FUSILEV ® 59 APNB believes 59 Denny Hamlin Greg Biffle 59 Premarket Approval PMA 59 modified glutathione analog 59 BiDil XR drug 59 PNP inhibitor 59 torsemide ER 59 ATRA IV 59 Bupropion HCl ER 59 MAb therapy 59 intranasal insulin product 59 incorporate CXA 59 INSPIRE Trial Phase III 59 lucinactant 59 Panflu TM 59 R lenalidomide 59 Perflubutane Polymer Microspheres 59 By Priyanka Dayal 59 proprietary transdermal patch 59 Zcom Networks Announces 59 ferumoxytol Injection 59 capromab pendetide kit 59 Grupo Simec Announces 59 Merck OSI Pharmaceuticals 59 Completes Enrollment 59 Coretec Announces 59 EGRIFTA TM 59 serine protease inhibitor CU# 59 Luveniq 59 candidate CRLX# 59 Ondansetron Injection 59 Lamotrigine Tablets 59 Launches Generic Version 59 tiapamil 59 SILENOR TM 59 please visit www.lexpharma.com 59 Phase III Pivotal 59 CysDisplay R 59 DPX Survivac 59 International LAB Pharma 59 serious cardiovascular thrombotic 59 PURPOSE OF SAFE HARBOR 59 Investigational Treatment 59 R sorafenib tablets 59 pulls Darvon painkiller 59 neuro inflammatory disorders 59 MSCRAMM ® 59 Testosterone Gel 59 USP Tablets PEPCID 59 kidney urologic 59 HuMax TAC 59 Asentar TM 59 R#/MEM # 59 zileuton CR 59 sarcoma melanoma 59 COLAZAL R 58 Ciclopirox 58 Executes Definitive 58 confirmatory pivotal 58 STEDESA 58 DNA methyltransferase inhibitors 58 AirBoss Announces 58 Fortical R 58 assigned PDUFA 58 NSE SUNPHARMA 58 ABL inhibitor completing 58 Entereg R 58 Arthritis Drugs 58 Risperidone Oral Solution 58 TRANSDUR Bupivacaine 58 4SC AG ISIN DE# 58 Receive Milestone Payment 58 JOULFERON 58 LibiGel ® testosterone gel 58 Spiegelmer ® 58 please visit http:/www.sunesis.com 58 ALN HPN 58 authority Gurian Sherman 58 proprietary bioresorbable polymer 58 www.allos.com 58 BayStreet.ca Research Alert 58 acetonide FA 58 NASDAQ MNKD focuses 58 Receives Stockholder Approval 58 Linjeta TM 58 experimental immunotherapeutics antivirals AmpligeGI mucosa resulting 58 Nasdaq IDRA biotechnology 58 AMITIZA ® 58 ELADUR 58 lender consents 58 Nanophase Announces 58 designated cethromycin 58 Delta opioid receptor 58 Pivotal Phase III 58 Drug Candidate 58 Phase 2a Clinical Trial 58 http:/www.anadyspharma.com 58 inflammatory PDE 58 Surfaxin lucinactant 58 www.ucb group.com 58 Clarifies Status 58 http:/www.marinabio.com 58 Therapeutic Competitors Companies 58 2 methoxyestradiol 58 oral prodrug 58 Gord Froehlich President 58 Vicor Technologies Announces 58 Begins Dosing 58 Stab stab 58 Synerx Pharma 58 Thelin TM 58 inflammatory autoimmune diseases 58 www.vivus.com 58 Restanza TM 58 TSX Delisting Review 58 Phase 2b Trial 58 HepeX B 58 ATPace TM 58 www.vioquestpharm.com 58 MEK Inhibitor 58 MGCD# MGCD# [001] 58 SPRYCEL ® 58 Phase III Trial 58 IND Investigational New 58 IG HCR ;) CO 58 human C1 inhibitor 58 StaphVAX R 58 Initiates Dosing 58 tramiprosate Alzhemed TM 58 TRISENOX R 58 Naglazyme R 58 Lenocta TM 58 evaluating picoplatin 58 Elagolix 58 HCV RNA polymerase 58 Evoltra ® 58 PI3K/Akt pathway inhibitor 58 PROSTASCINT R 58 Selective Electrochemical Tumor Ablation 58 SURFAXIN 58 www.biomimetics.com 58 Traci Arbios 58 recombinant PSMA vaccine 58 BiDil XR 58 evaluating bafetinib 58 degeneration gastrointestinal disorders 58 CYP#A# isoenzyme 58 NEBIDO R 58 Genentech Wyeth Pharmaceuticals 58 Emezine R 58 Alseres Cethrin 58 HGS ETR1 mapatumumab 58 ONSOLIS TM 58 Welichem 58 Janis Joplin soundalike respiratory 58 Trodusquemine MSI 58 fusion enhancers 58 www.spectrumpharm.com 58 TriPath Oncology 58 John Nebocat P.Eng 58 therefore therapeutically equivalent 58 Phase IIa Clinical Trial 58 mocetinostat MGCD# 58 www.medicago.com 58 commercialized DURECT 58 Biophan patent 58 AzaSite Xtra 58 commercializing Loramyc ® 58 AND ORAL STATEMENTS MADE 58 ALN PCS 58 Angiox ® 58 Nasdaq VNDA 58 Chemokine Therapeutics 58 Transcept Pharmaceuticals 58 Amerigo Announces 58 lead molecular radiotherapeutic 58 Horizant ™ 58 MBMI Closes 58 Ketotransdel 58 GVAX ® 58 Tezampanel 58 OxyContin Chernoff 58 dasatinib Sprycel ® 58 Kyowa Kirin 58 TKB# 58 By JENNIFER RADCLIFFE 58 Exalgo TM 58 Somatuline Depot 58 Captisol enabled 58 website http:/www.sinovac.com 58 Announces Poster Presentations 58 www.telik.com 58 Qutenza TM 58 Pink Sheets RHGP Renhuang 58 Immtech clinical trials 58 oral methylnaltrexone 58 R PEG uricase 58 Extended Release 58 manufacture PolyHeme 58 oncolytic virus therapies 58 Phusion Laboratories 58 Gregory P. Isenor 58 Kuvan TM sapropterin 58 rasagiline tablets 58 Confirmatory Phase 58 SUMAVEL 58 Engages CHF Investor Relations 58 Orosi Mill project 58 ADVEXIN p# therapy 58 Besivance 58 Pharma Merck Serono 58 visit www.noven.com 58 nephropathic cystinosis cystinosis 58 Circ Pharma 58 DMEP 58 MKC# MT 58 Fast Track designations 58 tranquilizers diazepam 58 Prodarsan R 58 TM pralatrexate injection 58 Anturol 58 express Luminex 58 Augment TM 58 Aphthasol R 58 Hereafter Inception Iron Man 58 damage cirrhosis liver 58 ZEVALIN ® 58 GLASSIA 58 Ketotransdel TM 58 developing Zerenex ferric 58 ischemic stroke neuropathic pain 58 Presents Preclinical Data 58 Schizophrenia Drug 57 PROGENSA R 57 Amends Private Placement 57 visit www.solitaireminerals.com 57 Luna Innovations Announces 57 Pruvel 57 Immunotherapeutic 57 http:/www.pharmacopeia.com 57 OMNARIS HFA 57 FDA Approvable Letter 57 Emily Blunt shimmered 57 PDL BioPharma Announces 57 venous thrombosis indications 57 targeting Inflammatory Bowel 57 Ostarine ™ 57 Decoding Financial 57 Receives Conditional 57 vosaroxin 57 Oracea R 57 includes VIAtab TM 57 TransVax tm 57 ABL inhibitor 57 Fovea Pharmaceuticals subsidiary 57 Licenses Novel 57 Marketing Authorisation Application MAA 57 Zingo TM 57 FOLFOX6 chemotherapy regimen 57 ARIAD Announces 57 market PolyHeme commercially 57 Renvela ® 57 dispositions joint ventures 57 OFIRMEV 57 NU# direct 57 Nanobody R 57 Retains CCG Investor Relations 57 markets Testim ® 57 Dalbavancin 57 STERIS Corporation Announces 57 THALOMID 57 website www.eurogascorp.com 57 http:/investors.formfactor.com/edgar.cfm 57 symbol PEH 57 rxRNA 57 XIAFLEX ™ 57 viii inability 57 Oral Insulin 57 Sunridge trades 57 Oxytrex TM 57 dimesylate Attention Deficit 57 Supplemental Biologics License Application 57 AvalonBay Communities Announces 57 CRHI 57 Peter Dasler P.Geo 57 Doxycycline Tablets 57 product Abreva R 57 pafuramidine maleate 57 Therapeutic Vaccine 57 COGECO subordinate voting 57 APF# NDA 57 Gabriel Mollet 57 Phase 2b Clinical Trial 57 5 HT3 antagonist 57 Restoraderm R 57 hide reddened eyes 57 visit www.parpharm.com 57 www.adeonapharma.com 57 VISICOL R 57 Archexin 57 Desvenlafaxine Succinate 57 Salary.com expressly disclaims 57 Completes Previously Announced 57 Web Site www.kinbauri 57 verdict elicited gasps 57 Rescula 57 CIMZIA r 57 Application BLA 57 sNDA submission 57 www.nanoviricides.com 57 evaluating intravenous picoplatin 57 Gel repository corticotropin injection 57 Trofex ™ 57 QRxPharma Limited 57 REMOXY ® 57 phase III isavuconazole 57 Civacir TM Hepatitis C 57 Release Tablets 57 http:/www.celgene.com 57 Marketing Authorisation Application 57 mergers dispositions 57 Chrysalin r rusalatide acetate 57 XIAFLEX ® 57 pentadentate logo R 57 Peter Mordaunt P.Geo 57 www.syntapharma.com 57 d l leucovorin 57 Quicksilver Resources filings 57 Pruvel ™ 57 PharMerica LTC Transaction 57 IsoTis stockholders 57 â € œwill â 57 Anti Inflammatory Drug 57 Combination REOLYSIN R 57 CB2 selective receptor agonist 57 BioDelivery Sciences Announces 57 PIX# trial 57 Other ImmunoGen collaborative 57 www.palatin.com 57 www.eurand.com 57 vapreotide acetate 57 Combunox 57 lexidronam injection 57 mark eOn 57 Pirfenidone 57 www.optimerpharma.com 57 AirIQ Announces 57 Cites Positive 57 document.getElementById root root 57 RECOTHROM R 57 Pafuramidine 57 website www.rxipharma.com 57 inhibitor PPI 57 investigating pralatrexate 57 biomimetics non 57 lorcaserin NDA 57 treat chronic sinusitis 57 IoGen ™ 57 management biostatistical analysis 57 IONSYS TM 57 Phase IIb Trial 57 OR SIMILAR STATEMENTS ARE 57 http:/www.urigen.com 57 Bicifadine 57 Cinryze ™ 57 Ceragenin ™ 57 glittering dupatta scarves 57 MYBA Announces Acquistion 57 www.durect.com 57 BioGlue R 57 stage hypoxia activated 57 Announce License Agreement 57 OTCBB PYTO 57 IgG1 monoclonal antibody 57 InSite reliance 57 Tablets #mg [002] 57 CCR9 antagonist 57 http:/www.bioalliancepharma.com 57 Connetics disclaims 57 commercialize BiDil 57 Novel Oral 57 Generic Versions 57 Orthopedic Advisory Panel 57 IND Filing 57 Phase 1b Clinical Trial 57 www.vicortech.com 57 APNB 57 APPY believes 57 IND CTA 57 Upcoming Deadline 57 CAUTIONARY STATEMENT UNDER 57 Quark Biotech 57 Receives Unsolicited 57 Epilepsy Drug 57 ProEthic Pharmaceuticals 57 Amex DEJ TSX Venture 57 vinorelbine tartrate 57 OTCQB CTIX 57 virus HCV protease inhibitor 57 novel proprietary KL4 57 Completes Non Brokered 57 Uvidem 57 Captisol ® 57 RNAi Therapeutics 57 ENTB 57 OvaRex ® MAb 57 BENLYSTA ® 57 Tesamorelin 57 Presents Preclinical 57 AusAm 57 IND Application 57 IoGen 57 mecarbil 57 Nasdaq NPSP announced 57 ZANAFLEX CAPSULES ® tizanidine 57 http:/www.torreypinestherapeutics.com 57 Codeine Phosphate 57 ZaBeCor 57 Silenor NDA 57 By JAMAAL ABDUL 57 LUNESTA TM 57 accessories autologous 57 Application MAA 57 Paramount Classics Insurge Pictures 57 Initiate Phase 57 2 inhibitor CYT# 57 visit http:/www.chinawindsystems.com 57 Lamictal ODT 57 HCV polymerase 57 Panzem ® 57 HEPLISAV TM 57 transmucosal delivery system 57 Thalomid R 57 mutually satisfactory definitive 57 http:/www.idenix.com 57 Poniard Pharmaceuticals Announces 56 NYSE Amex PTN 56 painting gouache watercolor 56 Nicotine Conjugate Vaccine 56 Vaccine Adjuvant 56 Prostate Cancer Vaccine 56 OmniComm intends 56 near Schefferville Quebec 56 http:/www.JazzPharmaceuticals.com 56 www.introgen.com 56 Dose Ranging Study 56 Dual Opioid TM 56 Firazyr ® 56 elbion GmbH 56 Friedreich Ataxia FRDA 56 Amlodipine Besylate 56 symbol KAB 56 refractory Hodgkin lymphoma 56 www.northfieldlabs.com 56 Simulect 56 information visit www.parpharm.com 56 PLAVIX R patent 56 http:/www.llnw.com 56 RIGScan ™ 56 gets USFDA nod 56 Generic Protonix 56 www.cytomedix.com 56 humanized therapeutic 56 MAA submission 56 Anti Nausea 56 By Thomas Gryta 56 E CENP E 56 TELINTRA 56 ALVESCO R 56 Raven biotechnologies inc 56 XL# XL# XL# 56 CapGen Offering 56 technology visit http:/www.genmab.com 56 MediGene focuses 56 symbol AZZ 56 CommVault beliefs 56 Protherics PLC announces 56 HYVISC R 56 Oral Spray 56 MK #B 56 AMITIZA R 56 agonistic human 56 Oroco Announces 56 treat dysmenorrhea 56 Stereotaxis Announces 56 acyclovir Lauriad R 56 Silenor ® 56 TSX Venture AHR 56 Oral Suspension USP 56 Ann Candelario 56 ANDA submission 56 CDK cyclin dependent 56 Progenta TM 56 www.oxigene.com 56 MAGE A3 ASCI 56 candidate MyVax 56 Inc. dba Vitro 56 http:/www.gpc-biotech.com 56 Dr. Gulfo 56 Comarco Announces 56 R galsulfase 56 TOCOSOL Camptothecin 56 testosterone gel LibiGel 56 Primera Bioscience 56 Jamaica ebullient Usain 56 Approvable 56 Valortim TM 56 symbol APE 56 www.nac tsx.com 56 RECOTHROM ® 56 Genitope Corporation 56 Aryplase 56 POSIDUR TM 56 VEGFR2 inhibitor 56 www.paintrials.com 56 oral nucleoside analogue 56 development diagnostics combinatorial 56 Soriatane 56 sulfonylhydrazine class 56 Fast Track Status 56 GTC recombinant human 56 oral taxane 56 R DYNACIN R 56 Phase IIb III 56 LUCASSIN 56 www.aastrom.com 56 Unsolicited Proposal From 56 Focalin XR ® 56 golf sportswear sweaters 56 CLIRS trial 56 Submits Application 56 Nasdaq MNKD focused 56 Pivotal Phase 56 Web Site http:/www.cryolife.com 56 Adnectin 56 Pharmos pipeline 56 www.amarincorp.com 56 KIDS FINANCIAL SKILLS 56 drug pipeline TAFA# 56 YOUR LOCAL ANIMAL SHELTER 56 TSX VENTURE BTR FRANKFURT 56 Stockholder Approval 56 Laich wristed 56 BLP# Liposome Vaccine 56 #L Sterilizer 56 PolyCides 56 Antigen Express website 56 commercialize Aganocides 56 Baqoubah north 56 Alnylam #x# 56 http:/www.agilysys.com 56 impacting WesBanco 56 novel VDA molecule 56 supplemental Biologics License Application 56 metformin accumulation 56 RNAi Therapeutic 56 Publication Classified Ad 56 opioid bowel dysfunction 56 Present Preclinical Data 56 Grants Orphan Drug 56 DOS# 56 certain protein tyrosine 56 R vancomycin hydrochloride 56 Alogliptin 56 Namenda Memantine HCl 56 GTC recombinant form 56 INTUNIV TM 56 Increases Bought Deal 56 EnPro Industries Announces 56 cancer indications bafetinib 56 ONSOLIS 56 should consult NeurogesX 56 novel synthetic PEGylated 56 AND OBJECTIVES OR 56 Plenaxis TM 56 estrogen receptor beta agonist 56 punter Mariani 56 compound CIP FENOFIBRATE 56 IMiDs ® 56 OTC BB PVCT 56 acne impetigo 56 Fuwei Films Announces 56 non nucleoside inhibitor 56 R Saizen R 56 MCSP respectively 56 QUADRAMET R 56 ZFP Therapeutics 56 Recommends Approval 56 please visit www.direxionshares.com 56 Nasdaq XTLB 56 Mails Offer 56 investigational antiplatelet agent 56 OLEPTRO ™ 56 Nasdaq Delisting Notice 56 INDICATED LOWER 56 induced mucositis 56 CYP#A# CYP#D# 56 Bazedoxifene 56 BioFocus DPI Galapagos 56 Long acting beta2 56 alvespimycin 56 Teasing caresses 56 Phase III Clinical Trials 56 #mg #mg [002] 56 Temoris Resources Inc. 56 Daytrana ™ 56 targeted anticancer biopharmaceuticals 56 hoFH